KaloBios Pharmaceuticals, Inc. announced that David W. Pritchard, president and chief executive officer, has decided to retire, effective immediately, and has also resigned his position as a member of the company's board of directors. The company has named Herb C. Cross, chief financial officer, as interim CEO pending a search for a new chief executive officer.